News + Filings Transactions
|
MOHANTY ADITYA P.
Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
08/15/2023 | BIORA THERAPEUTICS, INC. | PROG | Payment of Exercise | Common Stock | 117.9k | $3.14 | $370.1k | | 08/15/2023 |
08/15/2023 | BIORA THERAPEUTICS, INC. | PROG | Grant | Common Stock | 559.4k | $0.00 | $0 | | 08/15/2023 |
05/15/2023 | BIORA THERAPEUTICS, INC. | PROG | Payment of Exercise | Common Stock | 11.2k | $3.35 | $37.7k | | 05/15/2023 |
03/15/2023 | BIORA THERAPEUTICS, INC. | PROG | Grant | Common Stock | 155.6k | $0.00 | $0 | | 03/15/2023 |
03/15/2023 | BIORA THERAPEUTICS, INC. | PROG | Grant | Common Stock | 44.9k | $0.00 | $0 | | 03/15/2023 |
03/15/2023 | BIORA THERAPEUTICS, INC. | PROG | Payment of Exercise | Common Stock | 22.3k | $2.56 | $57k | | 03/15/2023 |
01/03/2023 | BIORA THERAPEUTICS, INC. | PROG | Disposition | Series X Preferred Stock | 178 | $0.00 | $0 | | 01/03/2023 |
11/15/2022 | BIORA THERAPEUTICS, INC. | PROG | Payment of Exercise | Common Stock | 175.1k | $0.27 | $47.3k | | 11/15/2022 |
05/15/2022 | BIORA THERAPEUTICS, INC. | PROG | Grant | Common Stock | 1.6M | $0.00 | $0 | | 05/15/2022 |
05/15/2022 | BIORA THERAPEUTICS, INC. | PROG | Grant | Stock Option (Right to Buy) | 2.5M | $0.75 | $1.9M | | 05/15/2022 |
11/08/2021 | BIORA THERAPEUTICS, INC. | PROG | Grant | Common Stock | 1.4M | $0.00 | $0 | | 11/08/2021 |
11/08/2021 | BIORA THERAPEUTICS, INC. | PROG | Grant | Stock Option (Right to Buy) | 2.1M | $3.54 | $7.4M | | 11/08/2021 |
07/17/2019 | Oncocyte Corp | OCX | Grant | Option to Purchase Common Stock | 45k | $2.12 | $95.4k | | 07/19/2019 |
02/15/2019 | Oncocyte Corp | OCX | Grant | Option to Purchase Common Stock | 33.8k | $3.80 | $128.2k | | 02/15/2019 |
07/10/2018 | Lineage Cell Therapeutics, Inc. | BTX | Exercise | Restricted Stock Units | 4.7k | $0.00 | $0 | | 07/10/2018 |
07/10/2018 | Lineage Cell Therapeutics, Inc. | BTX | Payment of Exercise | Common Shares, no par value | 1.6k | $2.20 | $3.6k | | 07/10/2018 |
04/10/2018 | Lineage Cell Therapeutics, Inc. | BTX | Exercise | Restricted Stock Units | 4.7k | $0.00 | $0 | | 04/10/2018 |
04/10/2018 | Lineage Cell Therapeutics, Inc. | BTX | Payment of Exercise | Common Shares, no par value | 1.6k | $2.49 | $4k | | 04/10/2018 |
03/15/2018 | Lineage Cell Therapeutics, Inc. | BTX | Grant | Option to Purchase Common Shares | 200k | $2.54 | $508k | | 03/15/2018 |
01/10/2018 | Lineage Cell Therapeutics, Inc. | BTX | Exercise | Restricted Stock Units | 4.7k | $0.00 | $0 | | 01/10/2018 |
01/10/2018 | Lineage Cell Therapeutics, Inc. | BTX | Payment of Exercise | Common Shares, no par value | 2.1k | $2.68 | $5.5k | | 01/10/2018 |
08/21/2017 | Lineage Cell Therapeutics, Inc. | BTX | Purchase | Common Shares, no par value | 7.5k | $2.50 | $18.8k | | 08/21/2017 |
06/06/2017 | Lineage Cell Therapeutics, Inc. | BTX | Grant | Option to Purchase Common Shares | 650k | $3.16 | $2.1M | | 06/06/2017 |
|